Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA: 603882)

Market Cap	16.51B
Revenue (ttm)	7.85B
Net Income (ttm)	161.20M
Shares Out	464.79M
EPS (ttm)	0.35
PE Ratio	102.90
Forward PE	26.22
Dividend	0.88 (2.53%)
Ex-Dividend Date	Jun 18, 2024

Volume	20,595,888
Open	33.00
Previous Close	33.24
Day's Range	32.70 - 36.52
52-Week Range	24.61 - 69.60
Beta	0.66
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Guangzhou Kingmed Diagnostics Group

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. The company also offers clinical research, health management, cold chain logistics, and scientific research services, as well as vitro diagnostics, big data, artificial intelligence, and forensic testing services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2006
• Employees: 11,586
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603882

Financial Performance

In 2023, Guangzhou Kingmed Diagnostics Group's revenue was 8.54 billion, a decrease of -44.82% compared to the previous year's 15.48 billion. Earnings were 643.38 million, a decrease of -76.64%.